Improving oncology biosimilar launches in the EU, the USA, and Japan: an updated Policy Review from the Southern Network on Adverse Reactions
Charles L. Bennett, Martin W. Schoen, Shamia Hoque, Bartlett J. Witherspoon, David M. Aboulafia, Catherine S. Hwang, Paul S. Ray, Paul R. Yarnold, Brian Chen, Benjamin Schooley, Matthew A. Taylor, Michael D. Wyatt, William J.M. Hrushesky, Y. Tony Yang
Topics & Concepts
BiosimilarMedicineAgency (philosophy)Adverse effectMedical prescriptionEuropean unionPharmacologyDrug approvalPharmacyFamily medicineBusinessInternal medicineDrugInternational tradeEpistemologyPhilosophyBiosimilars and Bioanalytical MethodsCAR-T cell therapy researchPharmaceutical Economics and Policy